IL2 and pulmonary edema: In 2010, Krieg et al. reported that pulmonary edema, one of the major side effects of IL-2, was abolished by using IL-2/anti-IL-2 Ab ICs to direct intermediate-affinity IL-2Rβγ or by eliminating CD25-mediated signals via the use of a blocking Ab or genetic disruption67.